It is being organised jointly by the Diabetes Research Society and the Novo Nordisk, a global leader in diabetes care.
Vice President of Novo Nordisk India Melvin D'Souza, said 'diabetes is an emergency in slow motion'.
He said diabetes 'is a very real threat to India's economy and developmental goals.'
The summit was inaugurated by Head of the Department of Endocrinology in the privately managed Pondicherry Institute of Medical Sciences (PIMS) Dr Ashok Kuma.
A release from the organising committee said around 300 experts from across the country and 30 internationally reputed faculty in the field of diabetes participated in the deliberations.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%